Conceptus(R) to Hold Second Quarter Financial Results Conference Call on July 31, 2012
Published on Thursday, 05 July 2012 16:38 Written by TradersHuddle Staff
MOUNTAIN VIEW, Calif., July 5, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading non-surgical permanent birth control method, today announced that the Company will release 2012 second quarter financial results on Tuesday, July 31, 2012, after the close of market. Management will host an investment community conference call beginning at 4:30 p.m. Eastern time on July 31, 2012, to discuss the results and answer questions.
Conference call dial-in information is as follows:
- U.S. callers: (888) 803-8296
- International callers: (706) 634-1250
Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company's website, www.conceptus.com.
A telephone replay will be available from 6:30 p.m. Eastern time on July 31, 2012, through 11:59 p.m. Eastern time on August 3, 2012. Replay dial-in information is as follows:
- U.S. callers: (855) 859-2056
- International callers: (404) 537-3406
- Conference ID number (U.S. and international): 97249487
- The replay will also be available at www.conceptus.com
About the Essure® Procedure
The Essure procedure, FDA approved since 2002, is the first permanent birth control method that can be performed in the comfort of a physician's office in less than 10 minutes (average hysteroscopic time) without hormones, cutting, burning or the risks associated with general anesthesia or tubal ligation. Soft, flexible inserts are placed in a woman's fallopian tubes through the cervix without incisions. Over the next three months, the body forms a natural barrier around and through the inserts to prevent sperm from reaching the egg. Three months after the Essure procedure, a doctor is able to perform an Essure Confirmation Test to confirm that the inserts are properly placed and that the fallopian tubes are fully blocked, allowing the patient to rely upon Essure for permanent birth control.
The Essure procedure is 99.83% effective based on five years of follow up with zero pregnancies reported in clinical trials, making it the most effective form of permanent birth control on the market. Essure's 10-year commercial data tracks closely with its five-year clinical results, and Essure has been proven and trusted by physicians since 2002. The Essure procedure is covered in the U.S. by most public and private insurance plans and more than 625,000 women worldwide have undergone the procedure.
About Conceptus®, Inc.
Conceptus, Inc. is the leader in the development of innovative device-based solutions in permanent birth control. The Company manufactures and markets the Essure procedure, which is available in the United States, Europe, Australia, New Zealand, Canada, Mexico, Central and South America and the Middle East.
Please visit www.essure.com for more information on the Essure procedure. Patients may call the Essure Information Center at 1-877-ESSURE-1 with questions or to find a physician in their area.
The Conceptus, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7961
© 2012 Conceptus, Inc.— All rights reserved.
Related Partner Headlines
- Conceptus Inc. Stock Downgraded (CPTS) - TheStreet.com
- Conceptus Inc. Stock Upgraded (CPTS) - TheStreet.com
- UPDATE: Piper Jaffray Downgrades Conceptus to Neutral on Macro Concerns - Benzinga
- UPDATE: Wunderlich Securities Raises PT to $18 on Conceptus; Hologic Settlement - Benzinga
- Conceptus Stock Hits New 52-Week High (CPTS) - TheStreet.com
- Conceptus(R) Announces Settlement of Patent Infringement Lawsuit With Hologic; Raises 2012 Financial Guidance - Benzinga
- Conceptus Receives FDA Approval for Compatible Use of Hologic's NovaSure with Essure Inserts in Place - Benzinga
- Conceptus Intends to Appeal Court Order in Hologic Patent Infringement Case - Benzinga
- Conceptus Stock Falls On Unusually High Volume (CPTS) - TheStreet.com
- Conceptus Stock Hits New 52-Week Low (CPTS) - TheStreet.com
Recent Trading Ideas
Chesapeake Energy Is Close to Resistance
Windstream Is Near its 50 Day Moving Average
Applied Materials Is Close to Resistance
E*TRADE is Near a Key Support Area
First Solar is Near a Key Support Area
Trading Idea: Is Monster Worldwide close to Support?
Trading Idea: - Is Walgreen close to Resistance?
Latest Partner Headlines
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com
Separating the Bargains From the Busts - TheStreet.com
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com
Gap Up and Sit - TheStreet.com
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com
Windows 8 PC Sales Disappointing: Report - TheStreet.com
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Dow JonesCompany ID [INDEXDJX:.DJI] Last trade:15,303.10 Trade time:4:36PM EDT Value change:▲8.60 (0.06%)
S&P 500Company ID [INDEXSP:.INX] Last trade:1,649.60 Trade time:4:35PM EDT Value change:▼0.91 (-0.06%)
NASDAQCompany ID [INDEXNASDAQ:.IXIC] Last trade:3,459.14 Trade time:5:15PM EDT Value change:▼0.28 (-0.01%)
In The Wires
Great Discounts Now: DressFirst.com's Prom Dresses
JM Internet (@jmgrp) Releases Small Business SEO Tip on Google Penguin Update 2.0
TideBuy.com Released Its New Bridal Lingerie Collection To Enrich Its Product Line
HomeThangs.com Introduces A Guide To Very Small Bathroom Vanities
Discounted Wedding Accessories Now At TBdress.com
UAE Men’s Grooming Products Market to Surpass USD 84 Million by 2018 Says TechSci Research
Care Continuum Alliance Filed Comments with EEOC in Support of the Value of Worksite Wellness and Incentives
JJsHouse Is Now Providing Big Discounts On Its Bridesmaid Dresses